Cosimo Altomare Università degli studi di Bari, Aldo Moro
Annelated medium-sized azaheterocycles as attractive scaffolds for CNS targeted leads

Roberta Costi Università degli studi di Roma, La Sapienza
The new era against neglected tropical diseases: fighting protozoa striking known and innovative targets

Claudio Dalvit Lavis, Trento
Ligand-based fluorine NMR screening: principles and applications in drug discovery

Marco De Vivo Istituto Italiano di Tecnologia (IIT)
Toward the computational design of nanoreceptors with intelligent recognition abilities

Barbara Gatto Università degli studi di Padova
Druggable targets in nucleic acids

Marco Lolli Università degli studi di Torino
Hydroxyazoles as carboxylate bioisosteres: an efficient tool for designing active compounds with added intellectual property value

Antonio Macchiarulo Università degli studi di Perugia
Unvealing uncharted pockets of IDO1 for novel therapeutic opportunities

Andrea Milelli Università di Bologna, Alma Mater Studiorum 
Histone deacetylase Inhibitors as multitarget ligands: new players in Alzheimer’s disease drug discovery?

Salvatore Di Maro, University “Luigi Vanvitelli”, Caserta, Italy
How we turned a weak and metabolically unstable CXCL12-mimic peptide into a stable, potent and selective CXCR4 antagonist: a successful peptide optimization story

Alberto Massarotti, University of Piemonte Orientale, Novara, Italy From ZINC to ZINClick: our way to explore the chemical space